KemPharm, Inc. is an early phase biopharmaceutical company located in the Iowa City, IA area near the campus of the University of Iowa. We are focused on the discovery and development of new, safer therapies for the treatment of Attention Deficit/Hyperactivity Disorder (ADHD), pain, and cardiovascular disease. KemPharm uses its patent-applied technology to improve existing drugs and shorten the development timeline while still maintaining a strong intellectual property position within each therapeutic area.

Contact Information
Christal McMickle
KemPharm Inc.
2500 Crosspark Road
Coralville, IA 52241
United States
Email Address: 
Phone Number: 
(319) 665-2575